Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

The LD50 for  acute dermal toxicity in rats is greater than 2000 mg/kg bw (OECD 423, GLP) (BASF 2012). No adverse effects were observed.

Key value for chemical safety assessment

Acute toxicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Quality of whole database:
valid without restriction

Additional information

Reliable data is available for acute dermal toxicity in rats (OECD 402, GLP) (BASF 2012). No indication of toxicity (local or systemic) was observed in the male and female rats that had been given a single dermal dose of 1000 or 2000 mg/kg bw.

Based on the physico-chemical properties, the substance is expected to permeate the skin easily. It is used as an intermediate in industrial settings. Therefore, the dermal route of exposure is considered to be the most relevant route.


Justification for selection of acute toxicity – dermal endpoint
only study available

Justification for classification or non-classification

Dangerous Substance Directive (67/548/EEC)

There is reliable and valid experimental data available for the acute dermal toxicity of the test substance. As a result the substance is considered to be not classified for acute dermal toxicity under Directive 67/548/EEC.

 

Classification, Labeling, and Packaging Regulation (EC) No. 1272/2008

There is reliable and valid experimental data available for the acute dermal toxicity of the test substance. As a result the substance is considered to be not classified for acute dermal toxicity under Regulation (EC) No.1272/2008, as amended for the third time in Directive EC 618/2012.